TY - JOUR
T1 - Neuronal imbalance of excitation and inhibition in schizophrenia
T2 - a scoping review of gamma-band ASSR findings
AU - Onitsuka, Toshiaki
AU - Tsuchimoto, Rikako
AU - Oribe, Naoya
AU - Spencer, Kevin M.
AU - Hirano, Yoji
N1 - Funding Information:
This study was supported by, JSPS KAKENHI Grant Nos. JP20KK0193 (Y.H.), JP18K07604 (Y.H.), JP19H00630 (Y.H.), JP19H03579 (Y.H.), JP21H02851 (Y.H.), JP19K08049 (N.O.) and 22K07617 (T.O.); AMED Grant Nos. JP20dm0207069 (T.O.) and JP19dm0107124h0004 (Y.H.); SIRS Research Fund Award (YH) from the Schizophrenia International Research Society; VA Merit I01 No. CX001443 (K.M.S.); NIH R01 No. MH093450 (K.M.S.). The funding sources had no further role in the writing report; and in the decision to submit the paper for publication.
Publisher Copyright:
© 2022 The Authors. Psychiatry and Clinical Neurosciences © 2022 Japanese Society of Psychiatry and Neurology.
PY - 2022
Y1 - 2022
N2 - Recent empirical findings suggest that altered neural synchronization, which is hypothesized to be associated with an imbalance of excitatory (E) and inhibitory (I) neuronal activities, may underlie a core pathophysiological mechanism in patients with schizophrenia. The auditory steady-state response (ASSR) examined by electroencephalography (EEG) and magnetoencephalography (MEG) has been proposed as a potential biomarker for evaluating altered neural synchronization in schizophrenia. For this review, we performed a comprehensive literature search for papers published between 1999 and 2021 examining ASSRs in patients with schizophrenia. Almost all EEG-ASSR studies reported gamma-band ASSR reductions, especially to 40-Hz stimuli both in power and/or phase synchronization in chronic and first-episode schizophrenia. In addition, similar to EEG-ASSR findings, MEG-ASSR deficits to 80-Hz stimuli (high gamma) have been reported in patients with schizophrenia. Moreover, the 40-Hz ASSR is likely to be a predictor of the onset of schizophrenia. Notably, increased spontaneous (or ongoing) broadband (30–100 Hz) gamma power has been reported during ASSR tasks, which resembles the increased spontaneous gamma activity reported in animal models of E/I imbalance. Further research on ASSRs and evoked and spontaneous gamma oscillations is expected to elucidate the pathophysiology of schizophrenia with translational implications.
AB - Recent empirical findings suggest that altered neural synchronization, which is hypothesized to be associated with an imbalance of excitatory (E) and inhibitory (I) neuronal activities, may underlie a core pathophysiological mechanism in patients with schizophrenia. The auditory steady-state response (ASSR) examined by electroencephalography (EEG) and magnetoencephalography (MEG) has been proposed as a potential biomarker for evaluating altered neural synchronization in schizophrenia. For this review, we performed a comprehensive literature search for papers published between 1999 and 2021 examining ASSRs in patients with schizophrenia. Almost all EEG-ASSR studies reported gamma-band ASSR reductions, especially to 40-Hz stimuli both in power and/or phase synchronization in chronic and first-episode schizophrenia. In addition, similar to EEG-ASSR findings, MEG-ASSR deficits to 80-Hz stimuli (high gamma) have been reported in patients with schizophrenia. Moreover, the 40-Hz ASSR is likely to be a predictor of the onset of schizophrenia. Notably, increased spontaneous (or ongoing) broadband (30–100 Hz) gamma power has been reported during ASSR tasks, which resembles the increased spontaneous gamma activity reported in animal models of E/I imbalance. Further research on ASSRs and evoked and spontaneous gamma oscillations is expected to elucidate the pathophysiology of schizophrenia with translational implications.
UR - http://www.scopus.com/inward/record.url?scp=85139843717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139843717&partnerID=8YFLogxK
U2 - 10.1111/pcn.13472
DO - 10.1111/pcn.13472
M3 - Review article
C2 - 36069299
AN - SCOPUS:85139843717
JO - Psychiatry and Clinical Neurosciences
JF - Psychiatry and Clinical Neurosciences
SN - 1323-1316
ER -